お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
606161

不眠症の世界市場:産業分析、規模、シェア、成長、動向および予測(2017年~2026年)

Insomnia Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2026

出版日: | 発行: Transparency Market Research | ページ情報: 英文 170 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.53円
不眠症の世界市場:産業分析、規模、シェア、成長、動向および予測(2017年~2026年)
出版日: 2018年01月25日
発行: Transparency Market Research
ページ情報: 英文 170 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Sleep Health Foundation によると、不眠症は世界人口の3分の1以上に影響を及ぼしていると推定されています。不眠症は、睡眠の開始および維持の困難性のような複数のパターンに基づいて特徴付けられ、これは通常、早すぎる覚醒および睡眠の再開または頻繁な覚醒を伴います。長期不眠症は、この疾患に罹患している個人の日常生活に影響を及ぼし、未治療のまま放置すると神経の衰弱または重度のうつ病にも関連してきます。特許を取得した分子と潜在的な臨床パイプライン薬候補の存在の増加は、不眠症の治療に期待をもたらしています。不眠症治療薬の需要は、老齢人口の増加と都市人口のストレスレベルの上昇により急激に上昇する見通しです。

当レポートでは、世界の不眠症市場について調査分析し、産業分析、市場規模と予測、セグメント別の市場分析、地域別の市場分析、競合情勢など、体系的な情報を提供しています。

目次

第1章 世界経済の見通し

第2章 エグゼクティブサマリー

第3章 市場概要

  • イントロダクション
    • 市場の分類
    • 市場の定義
  • 市場規模(百万米ドル)および予測:2012年~2026年
    • 対前年比成長率(YoY)
  • 市場のダイナミクス
  • サプライチェーン
  • コスト構造
  • 価格分析
  • 製品のライフサイクル
  • PESTLE分析
  • ディストリビューター一覧

第4章 市場分析と予測:2012年~2026年

  • 市場規模と予測:治療タイプ別
    • ベンゾジアゼピン
    • 非ベンゾジアゼピン系
    • 抗うつ薬
    • オレキシン拮抗薬
    • メラトニン拮抗薬
    • デバイス
    • 他の治療タイプ
  • 市場規模と予測:販売チャネル別
    • 病院薬局
    • 小売り薬局・薬剤店
    • オンライン薬局

第5章 北米

第6章 ラテンアメリカ

第7章 欧州

第8章 日本

第9章 アジア太平洋地域 (日本を除く)

第10章 中東・アフリカ地域

第11章 市場シェア、競合状況、企業プロファイル

  • 企業シェア分析
  • 競合情勢
  • 企業概要
    • Merck & Co Company
    • Sanofi
    • Pfizer Inc.
    • 武田薬品工業
    • Vanda Pharmaceuticals Inc.
    • Mylan NV
    • Teva Pharmaceutical Industries Limited
    • 大日本住友製薬
    • Paratek Pharmaceuticals, Inc.
    • Pernix Therapeutics Holdings, Inc.

第12章 調査方法

第13章 二次および一次ソース

第14章 前提と頭字語

第15章 免責事項

図表

List Of Table

  • TABLE 1 Global Insomnia Market Value (US$ Mn), 2012-2017
  • TABLE 2 Global Insomnia Market Value (US$ Mn), 2018-2026
  • TABLE 3 Global Insomnia Market Value (US$ Mn) and Y-o-Y, 2017-2026
  • TABLE 4 Global Benzodiazepines Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 5 Global Benzodiazepines Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 6 Global Benzodiazepines Segment Market Share, By Region 2012-2017
  • TABLE 7 Global Benzodiazepines Segment Market Share, By Region 2018-2026
  • TABLE 8 Global Benzodiazepines Segment Y-o-Y, By Region 2017-2026
  • TABLE 9 Global Nonbenzodiazepines Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 10 Global Nonbenzodiazepines Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 11 Global Nonbenzodiazepines Segment Market Share, By Region 2012-2017
  • TABLE 12 Global Nonbenzodiazepines Segment Market Share, By Region 2018-2026
  • TABLE 13 Global Nonbenzodiazepines Segment Y-o-Y, By Region 2017-2026
  • TABLE 14 Global Antidepressants Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 15 Global Antidepressants Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 16 Global Antidepressants Segment Market Share, By Region 2012-2017
  • TABLE 17 Global Antidepressants Segment Market Share, By Region 2018-2026
  • TABLE 18 Global Antidepressants Segment Y-o-Y, By Region 2017-2026
  • TABLE 19 Global Orexin Antagonist Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 20 Global Orexin Antagonist Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 21 Global Orexin Antagonist Segment Market Share, By Region 2012-2017
  • TABLE 22 Global Orexin Antagonist Segment Market Share, By Region 2018-2026
  • TABLE 23 Global Orexin Antagonist Segment Y-o-Y, By Region 2017-2026
  • TABLE 24 Global Melatonin Antagonist Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 25 Global Melatonin Antagonist Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 26 Global Melatonin Antagonist Segment Market Share, By Region 2012-2017
  • TABLE 27 Global Melatonin Antagonist Segment Market Share, By Region 2018-2026
  • TABLE 28 Global Melatonin Antagonist Segment Y-o-Y, By Region 2017-2026
  • TABLE 29 Global Devices Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 30 Global Devices Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 31 Global Devices Segment Market Share, By Region 2012-2017
  • TABLE 32 Global Devices Segment Market Share, By Region 2018-2026
  • TABLE 33 Global Devices Segment Y-o-Y, By Region 2017-2026
  • TABLE 34 Global Other Treatment Types Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 35 Global Other Treatment Types Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 36 Global Other Treatment Types Segment Market Share, By Region 2012-2017
  • TABLE 37 Global Other Treatment Types Segment Market Share, By Region 2018-2026
  • TABLE 38 Global Other Treatment Types Segment Y-o-Y, By Region 2017-2026
  • TABLE 39 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 40 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 41 Global Hospital Pharmacies Segment Market Share, By Region 2012-2017
  • TABLE 42 Global Hospital Pharmacies Segment Market Share, By Region 2018-2026
  • TABLE 43 Global Hospital Pharmacies Segment Y-o-Y, By Region 2017-2026
  • TABLE 44 Global Retail Pharmacies and Drug Stores Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 45 Global Retail Pharmacies and Drug Stores Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 46 Global Retail Pharmacies and Drug Stores Segment Market Share, By Region 2012-2017
  • TABLE 47 Global Retail Pharmacies and Drug Stores Segment Market Share, By Region 2018-2026
  • TABLE 48 Global Retail Pharmacies and Drug Stores Segment Y-o-Y, By Region 2017-2026
  • TABLE 49 Global Online Pharmacies Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 50 Global Online Pharmacies Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 51 Global Online Pharmacies Segment Market Share, By Region 2012-2017
  • TABLE 52 Global Online Pharmacies Segment Market Share, By Region 2018-2026
  • TABLE 53 Global Online Pharmacies Segment Y-o-Y, By Region 2017-2026
  • TABLE 54 North America Insomnia Market Value (US$ Mn), By Country 2012-2017
  • TABLE 55 North America Insomnia Market Value (US$ Mn), By Country 2018-2026
  • TABLE 56 North America Insomnia Market Value (US$ Mn), By Treatment Type 2012-2017
  • TABLE 57 North America Insomnia Market Value (US$ Mn), By Treatment Type 2018-2026
  • TABLE 58 North America Insomnia Market Value (US$ Mn), By Sales Channel 2012-2017
  • TABLE 59 North America Insomnia Market Value (US$ Mn), By Sales Channel 2018-2026
  • TABLE 60 Latin America Insomnia Market Value (US$ Mn), By Country 2012-2017
  • TABLE 61 Latin America Insomnia Market Value (US$ Mn), By Country 2018-2026
  • TABLE 62 Latin America Insomnia Market Value (US$ Mn), By Treatment Type 2012-2017
  • TABLE 63 Latin America Insomnia Market Value (US$ Mn), By Treatment Type 2018-2026
  • TABLE 64 Latin America Insomnia Market Value (US$ Mn), By Sales Channel 2012-2017
  • TABLE 65 Latin America Insomnia Market Value (US$ Mn), By Sales Channel 2018-2026
  • TABLE 66 Europe Insomnia Market Value (US$ Mn), By Country 2012-2017
  • TABLE 67 Europe Insomnia Market Value (US$ Mn), By Country 2018-2026
  • TABLE 68 Europe Insomnia Market Value (US$ Mn), By Treatment Type 2012-2017
  • TABLE 69 Europe Insomnia Market Value (US$ Mn), By Treatment Type 2018-2026
  • TABLE 70 Europe Insomnia Market Value (US$ Mn), By Sales Channel 2012-2017
  • TABLE 71 Europe Insomnia Market Value (US$ Mn), By Sales Channel 2018-2026
  • TABLE 72 Japan Insomnia Market Value (US$ Mn), By Country 2012-2017
  • TABLE 73 Japan Insomnia Market Value (US$ Mn), By Country 2018-2026
  • TABLE 74 Japan Insomnia Market Value (US$ Mn), By Treatment Type 2012-2017
  • TABLE 75 Japan Insomnia Market Value (US$ Mn), By Treatment Type 2018-2026
  • TABLE 76 Japan Insomnia Market Value (US$ Mn), By Sales Channel 2012-2017
  • TABLE 77 Japan Insomnia Market Value (US$ Mn), By Sales Channel 2018-2026
  • TABLE 78 APEJ Insomnia Market Value (US$ Mn), By Country 2012-2017
  • TABLE 79 APEJ Insomnia Market Value (US$ Mn), By Country 2018-2026
  • TABLE 80 APEJ Insomnia Market Value (US$ Mn), By Treatment Type 2012-2017
  • TABLE 81 APEJ Insomnia Market Value (US$ Mn), By Treatment Type 2018-2026
  • TABLE 82 APEJ Insomnia Market Value (US$ Mn), By Sales Channel 2012-2017
  • TABLE 83 APEJ Insomnia Market Value (US$ Mn), By Sales Channel 2018-2026
  • TABLE 84 MEA Insomnia Market Value (US$ Mn), By Country 2012-2017
  • TABLE 85 MEA Insomnia Market Value (US$ Mn), By Country 2018-2026
  • TABLE 86 MEA Insomnia Market Value (US$ Mn), By Treatment Type 2012-2017
  • TABLE 87 MEA Insomnia Market Value (US$ Mn), By Treatment Type 2018-2026
  • TABLE 88 MEA Insomnia Market Value (US$ Mn), By Sales Channel 2012-2017
  • TABLE 89 MEA Insomnia Market Value (US$ Mn), By Sales Channel 2018-2026

List Of Figures

  • FIG. 1 Global Insomnia Market Value (US$ Mn), 2012-2017
  • FIG. 2 Global Insomnia Market Value (US$ Mn) Forecast, 2018-2026
  • FIG. 3 Global Insomnia Market Value (US$ Mn) and Y-o-Y, 2017-2026
  • FIG. 4 Global Benzodiazepines Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 5 Global Benzodiazepines Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 6 Global Benzodiazepines Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 7 Global Nonbenzodiazepines Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 8 Global Nonbenzodiazepines Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 9 Global Nonbenzodiazepines Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 10 Global Antidepressants Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 11 Global Antidepressants Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 12 Global Antidepressants Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 13 Global Orexin Antagonist Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 14 Global Orexin Antagonist Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 15 Global Orexin Antagonist Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 16 Global Melatonin Antagonist Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 17 Global Melatonin Antagonist Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 18 Global Melatonin Antagonist Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 19 Global Devices Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 20 Global Devices Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 21 Global Devices Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 22 Global Other Treatment Types Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 23 Global Other Treatment Types Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 24 Global Other Treatment Types Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 25 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 26 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 27 Global Hospital Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 28 Global Retail Pharmacies and Drug Stores Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 29 Global Retail Pharmacies and Drug Stores Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 30 Global Retail Pharmacies and Drug Stores Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 31 Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 32 Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 33 Global Online Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 34 North America Insomnia Market Value (US$ Mn), By Country 2012-2017
  • FIG. 35 North America Insomnia Market Value (US$ Mn), By Country 2018-2026
  • FIG. 36 North America Insomnia Market Value (US$ Mn), By Treatment Type 2012-2017
  • FIG. 37 North America Insomnia Market Value (US$ Mn), By Treatment Type 2018-2026
  • FIG. 38 North America Insomnia Market Value (US$ Mn), By Sales Channel 2012-2017
  • FIG. 39 North America Insomnia Market Value (US$ Mn), By Sales Channel 2018-2026
  • FIG. 40 Latin America Insomnia Market Value (US$ Mn), By Country 2012-2017
  • FIG. 41 Latin America Insomnia Market Value (US$ Mn), By Country 2018-2026
  • FIG. 42 Latin America Insomnia Market Value (US$ Mn), By Treatment Type 2012-2017
  • FIG. 43 Latin America Insomnia Market Value (US$ Mn), By Treatment Type 2018-2026
  • FIG. 44 Latin America Insomnia Market Value (US$ Mn), By Sales Channel 2012-2017
  • FIG. 45 Latin America Insomnia Market Value (US$ Mn), By Sales Channel 2018-2026
  • FIG. 46 Europe Insomnia Market Value (US$ Mn), By Country 2012-2017
  • FIG. 47 Europe Insomnia Market Value (US$ Mn), By Country 2018-2026
  • FIG. 48 Europe Insomnia Market Value (US$ Mn), By Treatment Type 2012-2017
  • FIG. 49 Europe Insomnia Market Value (US$ Mn), By Treatment Type 2018-2026
  • FIG. 50 Europe Insomnia Market Value (US$ Mn), By Sales Channel 2012-2017
  • FIG. 51 Europe Insomnia Market Value (US$ Mn), By Sales Channel 2018-2026
  • FIG. 52 Japan Insomnia Market Value (US$ Mn), By Country 2012-2017
  • FIG. 53 Japan Insomnia Market Value (US$ Mn), By Country 2018-2026
  • FIG. 54 Japan Insomnia Market Value (US$ Mn), By Treatment Type 2012-2017
  • FIG. 55 Japan Insomnia Market Value (US$ Mn), By Treatment Type 2018-2026
  • FIG. 56 Japan Insomnia Market Value (US$ Mn), By 2012-2017
  • FIG. 57 Japan Insomnia Market Value (US$ Mn), By Sales Channel 2018-2026
  • FIG. 58 APEJ Insomnia Market Value (US$ Mn), By Country 2012-2017
  • FIG. 59 APEJ Insomnia Market Value (US$ Mn), By Country 2018-2026
  • FIG. 60 APEJ Insomnia Market Value (US$ Mn), By Treatment Type 2012-2017
  • FIG. 61 APEJ Insomnia Market Value (US$ Mn), By Treatment Type 2018-2026
  • FIG. 62 APEJ Insomnia Market Value (US$ Mn), By Sales Channel 2012-2017
  • FIG. 63 APEJ Insomnia Market Value (US$ Mn), By Sales Channel 2018-2026
  • FIG. 64 MEA Insomnia Market Value (US$ Mn), By Country 2012-2017
  • FIG. 65 MEA Insomnia Market Value (US$ Mn), By Country 2018-2026
  • FIG. 66 MEA Insomnia Market Value (US$ Mn), By Treatment Type 2012-2017
  • FIG. 67 MEA Insomnia Market Value (US$ Mn), By Treatment Type 2018-2026
  • FIG. 68 MEA Insomnia Market Value (US$ Mn), By Sales Channel 2012-2017
  • FIG. 69 MEA Insomnia Market Value (US$ Mn), By Sales Channel 2018-2026
目次

Title:
Insomnia Market (Treatment Type - Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonist, Melatonin Antagonist, Devices, and Other Treatment Types; Sales Channel - Hospital Pharmacies, Retail Pharmacies and Drug Stores, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2026.

According to the Sleep Health Foundation, Insomnia has been estimated to affect over one-third of the global population. Insomnia is characterized on the basis of multiple patterns such as difficulty in sleep initiation & maintenance that is usually accompanied with awakening too early & trouble sleeping again or frequent awakenings. Long-term insomnia has impacted daily life of individuals suffering from the disease, and has been associated with nervous breakdown or severe depression if left untreated. Increasing presence of patented molecules and potential clinical pipeline drug candidates hold promise in the treatment of insomnia. Demand for insomnia therapeutics will witness a tremendous rise on the back of growing geriatric population, and rising stress level among the urban population.

Transparency Market Research (TMR) has published a new insightful report on the global insomnia market. The report delivers forecasts on the global insomnia market, and examines the market in detail, providing important dynamics affecting the market expansion. Along with the provision of information on latest market trends, restraining factors, and augmenting factors impacting growth of the market, analysis on the data regarding multiple market parameters has been included in the report.

Report Structure

The report's initiates with a chapter titled "executive summary", which issues a summation of global insomnia market coupled with the information on imperative market numbers such as historical CAGR (2012-2016) and forecast CAGR (2017-2026). These numbers rendered are associated with the market segments incorporated in the report. Trailing the executive summary is a chapter titled "overview" that incorporates the definition of "insomnia", which succeeds an incisive market introduction. The overview chapter clearly describes the wide scope of global insomnia market. Some chapters in the report offer information on the pricing analysis coupled with the cost structure regarding the global insomnia market.

Competition Landscape

A scrupulous analysis regarding the global insomnia market's competition landscape has been issued in the concluding chapter of this report, incorporating information on prominent industries that significantly contribute to the market expansion. Occupancy of these market participants is tracked with the aid of an intensity map. Profiling key market participants rigorously, this chapter offers insights based on SWOT analysis, key developments, key financials, company overview, and product overview.

Research Methodology

A robust research methodology, proven & tested, has been employed by TMR's analysts to develop the report on global insomnia market. The research methodology used has helped analysts in offering accurate insights related to the global insomnia market. It depends entirely upon the secondary and primary researches, for gaining important information associated with the market. The information compiled has then been validated by the analysts several times for ensuring the report's authenticity, and for making it a reliable & authoritative source of reference for readers of the report.

Table of Contents

1. Global Economic Outlook

2. Global Insomnia Market - Executive Summary

3. Global Insomnia Market Overview

  • 3.1. Introduction
    • 3.1.1. Global Insomnia Market Taxonomy
    • 3.1.2. Global Insomnia Market Definition
  • 3.2. Global Insomnia Market Size (US$ Mn) and Forecast, 2012-2026
    • 3.2.1. Global Insomnia Market Y-o-Y Growth
  • 3.3. Global Insomnia Market Dynamics
  • 3.4. Supply Chain
  • 3.5. Cost Structure
  • 3.6. Pricing Analysis
  • 3.7. Product Life Cycle
  • 3.8. PESTLE Analysis
  • 3.9. List of Distributors

4. Global Insomnia Market Analysis and Forecast 2012-2026

  • 4.1. Global Insomnia Market Size and Forecast By Treatment Type, 2012-2026
    • 4.1.1. Benzodiazepines Market Size and Forecast, 2012-2026
      • 4.1.1.1. Revenue (US$ Mn) Comparison, By Region
      • 4.1.1.2. Market Share Comparison, By Region
      • 4.1.1.3. Y-o-Y growth Comparison, By Region
    • 4.1.2. Nonbenzodiazepines Market Size and Forecast, 2012-2026
      • 4.1.2.1. Revenue (US$ Mn) Comparison, By Region
      • 4.1.2.2. Market Share Comparison, By Region
      • 4.1.2.3. Y-o-Y growth Comparison, By Region
    • 4.1.3. Antidepressants Market Size and Forecast, 2012-2026
      • 4.1.3.1. Revenue (US$ Mn) Comparison, By Region
      • 4.1.3.2. Market Share Comparison, By Region
      • 4.1.3.3. Y-o-Y growth Comparison, By Region
    • 4.1.4. Orexin Antagonist Market Size and Forecast, 2012-2026
      • 4.1.4.1. Revenue (US$ Mn) Comparison, By Region
      • 4.1.4.2. Market Share Comparison, By Region
      • 4.1.4.3. Y-o-Y growth Comparison, By Region
    • 4.1.5. Melatonin Antagonist Market Size and Forecast, 2012-2026
      • 4.1.5.1. Revenue (US$ Mn) Comparison, By Region
      • 4.1.5.2. Market Share Comparison, By Region
      • 4.1.5.3. Y-o-Y growth Comparison, By Region
    • 4.1.6. Devices Market Size and Forecast, 2012-2026
      • 4.1.6.1. Revenue (US$ Mn) Comparison, By Region
      • 4.1.6.2. Market Share Comparison, By Region
      • 4.1.6.3. Y-o-Y growth Comparison, By Region
    • 4.1.7. Other Treatment Types Market Size and Forecast, 2012-2026
      • 4.1.7.1. Revenue (US$ Mn) Comparison, By Region
      • 4.1.7.2. Market Share Comparison, By Region
      • 4.1.7.3. Y-o-Y growth Comparison, By Region
  • 4.2. Global Insomnia Market Size and Forecast By Sales Channel, 2012-2026
    • 4.2.1. Hospital Pharmacies Market Size and Forecast, 2012-2026
      • 4.2.1.1. Revenue (US$ Mn) Comparison, By Region
      • 4.2.1.2. Market Share Comparison, By Region
      • 4.2.1.3. Y-o-Y growth Comparison, By Region
    • 4.2.2. Retail Pharmacies and Drug Stores Market Size and Forecast, 2012-2026
      • 4.2.2.1. Revenue (US$ Mn) Comparison, By Region
      • 4.2.2.2. Market Share Comparison, By Region
      • 4.2.2.3. Y-o-Y growth Comparison, By Region
    • 4.2.3. Online Pharmacies Market Size and Forecast, 2012-2026
      • 4.2.3.1. Revenue (US$ Mn) Comparison, By Region
      • 4.2.3.2. Market Share Comparison, By Region
      • 4.2.3.3. Y-o-Y growth Comparison, By Region

5. North America Insomnia Market Size and Forecast, 2012-2026

  • 5.1. North America Outlook
  • 5.2. North America Parent Market Outlook
  • 5.3. North America Target Market Outlook
  • 5.4. Revenue (US$ Mn) Comparison, By Country
    • 5.4.1. US Market Size and Forecast (US$ Mn), 2012-2026
    • 5.4.2. Canada Market Size and Forecast (US$ Mn), 2012-2026
  • 5.5. Revenue (US$ Mn) Comparison, By Treatment Type
  • 5.6. Revenue (US$ Mn) Comparison, By Sales Channel

6. Latin America Insomnia Market Size and Forecast, 2012-2026

  • 6.1. Latin America Outlook
  • 6.2. Latin America Parent Market Outlook
  • 6.3. Latin America Target Market Outlook
  • 6.4. Revenue (US$ Mn) Comparison, By Country
    • 6.4.1. Brazil Market Size and Forecast (US$ Mn), 2012-2026
    • 6.4.2. Mexico Market Size and Forecast (US$ Mn), 2012-2026
    • 6.4.3. Rest of Latin America Market Size and Forecast (US$ Mn), 2012-2026
  • 6.5. Revenue (US$ Mn) Comparison, By Treatment Type
  • 6.6. Revenue (US$ Mn) Comparison, By Sales Channel

7. Europe Insomnia Market Size and Forecast, 2012-2026

  • 7.1. Europe Outlook
  • 7.2. Europe Parent Market Outlook
  • 7.3. Europe Target Market Outlook
  • 7.4. Revenue (US$ Mn) Comparison, By Country
    • 7.4.1. Germany Market Size and Forecast (US$ Mn), 2012-2026
    • 7.4.2. UK Market Size and Forecast (US$ Mn), 2012-2026
    • 7.4.3. France Market Size and Forecast (US$ Mn), 2012-2026
    • 7.4.4. Spain Market Size and Forecast (US$ Mn), 2012-2026
    • 7.4.5. Italy Market Size and Forecast (US$ Mn), 2012-2026
    • 7.4.6. Rest of Europe Market Size and Forecast (US$ Mn), 2012-2026
  • 7.5. Revenue (US$ Mn) Comparison, By Treatment Type
  • 7.6. Revenue (US$ Mn) Comparison, By Sales Channel

8. Japan Insomnia Market Size and Forecast, 2012-2026

  • 8.1. Japan Outlook
  • 8.2. Japan Parent Market Outlook
  • 8.3. Japan Target Market Outlook
  • 8.4. Revenue (US$ Mn) Comparison, By Country
    • 8.4.1. Japan Market Size and Forecast (US$ Mn), 2012-2026
  • 8.5. Revenue (US$ Mn) Comparison, By Treatment Type
  • 8.6. Revenue (US$ Mn) Comparison, By Sales Channel

9. APEJ Insomnia Market Size and Forecast, 2012-2026

  • 9.1. APEJ Outlook
  • 9.2. APEJ Parent Market Outlook
  • 9.3. APEJ Target Market Outlook
  • 9.4. Revenue (US$ Mn) Comparison, By Country
    • 9.4.1. China Market Size and Forecast (US$ Mn), 2012-2026
    • 9.4.2. India Market Size and Forecast (US$ Mn), 2012-2026
    • 9.4.3. Thailand Market Size and Forecast (US$ Mn), 2012-2026
    • 9.4.4. Singapore Market Size and Forecast (US$ Mn), 2012-2026
    • 9.4.5. Australia Market Size and Forecast (US$ Mn), 2012-2026
    • 9.4.6. Rest of APEJ Market Size and Forecast (US$ Mn), 2012-2026
  • 9.5. Revenue (US$ Mn) Comparison, By Treatment Type
  • 9.6. Revenue (US$ Mn) Comparison, By Sales Channel

10. MEA Insomnia Market Size and Forecast, 2012-2026

  • 10.1. MEA Outlook
  • 10.2. MEA Parent Market Outlook
  • 10.3. MEA Target Market Outlook
  • 10.4. Revenue (US$ Mn) Comparison, By Country
    • 10.4.1. GCC Countries Market Size and Forecast (US$ Mn), 2012-2026
    • 10.4.2. South Africa Market Size and Forecast (US$ Mn), 2012-2026
    • 10.4.3. Nigeria Market Size and Forecast (US$ Mn), 2012-2026
    • 10.4.4. Rest of MEA Market Size and Forecast (US$ Mn), 2012-2026
  • 10.5. Revenue (US$ Mn) Comparison, By Treatment Type
  • 10.6. Revenue (US$ Mn) Comparison, By Sales Channel

11. Global Insomnia Market Company Share, Competition Landscape and Company Profiles

  • 11.1. Company Share Analysis
  • 11.2. Competition Landscape
  • 11.3. Company Profiles
    • 11.3.1. Merck & Co Company
    • 11.3.2. Sanofi
    • 11.3.3. Pfizer Inc.
    • 11.3.4. Takeda Pharmaceutical Company Limited
    • 11.3.5. Vanda Pharmaceuticals Inc.
    • 11.3.6. Mylan N.V.
    • 11.3.7. Teva Pharmaceutical Industries Limited
    • 11.3.8. Sumitomo Dainippon Pharma Co., Ltd.
    • 11.3.9. Paratek Pharmaceuticals, Inc.
    • 11.3.10. Pernix Therapeutics Holdings, Inc.

12. Research Methodology

13. Secondary and Primary Sources

14. Assumptions and Acronyms

15. Disclaimer

株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.